Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture model

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  De Boer, Anna A ^a   Monk, Jennifer M ^a   Robinson, Lindsay E ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALBUMIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 10;

ADIPOCYTE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CONTACT; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; GENE; GENE EXPRESSION; IN VITRO STUDY; MACROPHAGE; MCP1 GENE; MCP1 IP GENE; MOUSE; NFKB GENE; NONHUMAN; NOS2 GENE; OBESITY; TGFB1 GENE; TNFA GENE; 3T3 CELL LINE; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINE; CHEMOKINE CCL2; COCULTURE TECHNIQUES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908304356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085037     Document Type: Article

References (46)

1. Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316: 129-139.
2. Surmi BK, Hasty AH (2008) Macrophage infiltration into adipose tissue: Initiation, propagation and remodeling. Future lipidol 3: 545-556.
3. Suganami T, Nishida J, Ogawa Y (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25: 2062-2068. (Pubitemid 41416301)
4. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27: 84-91. (Pubitemid 46370478)
5. Ajuwon KM, Spurlock ME (2005) Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135: 1841-1846. (Pubitemid 41099739)
6. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, et al. (2003) Differential modulation of toll-like receptors by fatty acids preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44: 479-486. (Pubitemid 37279695)
7. Narazaki M, Fujimoto M, Matsumoto T, Morita Y, Saito H, et al. (1998) Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signalling. Proc Natl Acad Sci USA 95: 13130-13134. (Pubitemid 28509536)
8. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, et al. (2009) Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190.
9. Scheele C, Nielsen S, Kelly M, Broholm C, Nielsen AR, et al. (2012) Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One 7: e39657.
10. Lumeng CN, DeYoung SM, Bodzin JL, Saltiel AR (2007) Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56: 16-23.
11. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184. (Pubitemid 46048464)
12. Lumeng CN, Deyoung SM, Saltiel AR (2007) Macrophages block insulin action in adipocytes by altering expression of signalling and glucose transport proteins. Am J Physiol Endocrinol Metab292: E166-E174. (Pubitemid 46052939)
13. Abel ED, Peroni O, Kim JK, Kim Y, Boss O (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733. (Pubitemid 32144519)
14. Calder PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: S1505-1519S.
15. Turk HF, Chapkin RS (2012) Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids. Prostaglandins, Leukot Essent Fatty Acids 88: 43-47.
16. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar M, et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394-397. (Pubitemid 43185410)
17. Todoric J, Löffler M, Huber J, Bilban M, Reimers M, et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49: 2109-2119. (Pubitemid 44168479)
18. Oster RT, Tishinsky JM, Yuan Z, Robinson LE (2010) Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARγ mRNA, in 3T3-L1 adipocytes. Appl Physiol Nutr Metab35: 783-789.
19. Tishinsky JM, Ma DW, Robinson LE (2010) Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes. Obesity 19: 262-268.
20. Park P, McMullen MR, Huang H, Thakur V, Nagy LE (2007) Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-α (TNF-α) expression via ERK1/2 activation and egr-1 expression: role of TNF-α in adiponectin-stimulated interleukin-10 production. J Biol Chem 282: 21695-21703. (Pubitemid 47195777)
21. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE (2011) Molecular mechanism for adiponectin-dependent M2 macrophage polarization link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem 286: 13460-13469.
22. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
23. Wilson S, Wong M, Stryjecki C, De Boer A, Lui E, et al. (2013) Unraveling the adipocyte inflammomodulatory pathways activated by North American ginseng. Int J Obes (Lond) 37: 350-356.
24. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, et al. (2002) T0070907, a selective ligand for peroxisome proliferator-activated receptor γ, functions as an antagonist of biochemical and cellular activities. J Biol Chem 277: 19649-19657. (Pubitemid 34967479)
25. Xie L, Ortega MT, Mora S, Chapes SK (2010) Interactive changes between macrophages and adipocytes. Clin Vaccine Immunol 17: 651-659.
26. Oliver E, McGillicuddy FC, Harford KA, Reynolds CM, Phillips CM, et al. (2012) Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J Nutr Biochem 23: 1192-1200.
27. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS (2010) Dynamic, M2-like remodeling phenotypes of CD11c adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59: 1171-1181.
28. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 122: 787-795.
29. Chen C, Chang Y, Tsi C, Lin W (2003) Inhibition of IFN-γ-mediated inducible nitric oxide synthase induction by the peroxisome proliferator- activated receptor γ agonist, 15-deoxy-Δ12, 14-prostaglandin J2, involves inhibition of the upstream janus kinase/STAT1 signalling pathway. J Immunol 171: 979-988. (Pubitemid 36871413)
30. Takahashi K, Yamaguchi S, Shimoyama T, Seki H, Miyokawa K, et al. (2008) JNK-and IκB-dependent pathways regulate MCP1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro. Am J Physiol Endocrinol Metab 294: E898-E909.
31. Hsueh HW, Zhou Z, Whelan J, Allen KG, Moustaid-Moussa N, et al. (2011) Stearidonic and eicosapentaenoic acids inhibit interleukin-6 expression in ob/ob mouse adipose stem cells via toll-like receptor-2-Mediated pathways. J Nutr 141: 1260-1266.
32. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
33. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, et al. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437: 759-763. (Pubitemid 41486547)
34. Greene M, Blumberg B, McBride O, Yi H, Kronquist K, et al. (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Expr 4: 281-289.
35. Martin H (2010) Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat Res. 690:57-63.
36. Kadegowda A, Bionaz M, Piperova L, Erdman R, Loor J (2009) Peroxisome proliferator-activated receptor-γ activation and long-chain fatty acids alter lipogenic gene networks in bovine mammary epithelial cells to various extents. J Dairy Sci 92: 4276-4289.
37. Lolmède K, Duffaut C, Zakaroff-Girard A, Bouloumié A (2011) Immune cells in adipose tissue: Key players in metabolic disorders. Diabetes Metab 37: 283-290.
38. Titos E, Rius B, González-Périz A, López-Vicario C, Morán-Salvador E, et al. (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. JImmunol 187: 5408-5418.
39. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK (2003) PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages. Proc Natl Acad Sci USA 100: 6712-6717. (Pubitemid 36666645)
40. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, et al. (2007) Macrophage-specific PPARgamma; controls alternative activation and improves insulin resistance. Nature 447: 1116-1120. (Pubitemid 47014427)
41. Thieringer R, Fenyk-Melody JE, Le Grand CB, Shelton BA, Detmers PA, et al. (2000) Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol 164: 1046-1054. (Pubitemid 30043733)
42. Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, et al. (2011) Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation. Nature 477: 477-481.
43. Varga T, Czimmerer Z, Nagy L (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 1812: 1007-1022.
44. Lee JY, Sohn KH, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 276: 16683-16689.
45. Han CY, Kargi AY, Omer M, Chan CK, Wabitsch M, et al. (2010) Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes dissociation of adipocyte hypertrophy from inflammation. Diabetes 59: 386-396.
46. Bradley RL, Fisher FM, Maratos-Flier E (2008) Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes. Obesity 16: 938-944. (Pubitemid 351620481)